Business Context and Reporting Period
Company: Anteris Technologies Global Corp. (AVR)
Filing Type: Form 8-K (Current Report)
Date of Report: October 23, 2025
Reporting Period: Event date October 23, 2025 (October 24, 2025 AEST)
Business Context: The Company, an emerging growth company incorporated in Delaware with principal offices in Australia, announced a private placement of equity securities and warrants.
Key Financial Metrics and Transaction Details
Transaction Overview: The Company entered into subscription agreements and confirmation letters to sell equity and warrants in two tranches:
- Common Stock Offering: Sale of 2,244,896 shares of Common Stock and accompanying five-year warrants to purchase an equal number of shares.
- CDI Offering: Sale of 2,788,064 CHESS Depositary Interests (CDIs) and accompanying five-year warrants to purchase an equal number of CDIs.
- Expected Gross Proceeds: Approximately US$25 million in aggregate.
- Lead Manager: Evolution Capital Pty Ltd (for the CDI Offering), receiving 250,000 CDI Warrants.
Warrant Terms:
- Common Stock Warrants: Exercise price of $7.50 per share; exercisable commencing six months after issuance.
- CDI Warrants: Exercise price of A$11.50 per CDI; exercisable commencing six months after issuance.
Financial Metrics (Revenue, Profit, Cash Flow, Debt): The filing text does not provide a clear value for current revenue, profit, cash flow, margins, debt, or liquidity positions. This report focuses solely on the capital raise transaction.
Material Changes and Closing Conditions
Expected Closing Dates:
- Common Stock Offering: Expected to close on or around October 27, 2025.
- CDI Offering: Expected to settle on or around October 30, 2025.
Conditions: Closings are subject to customary closing conditions. The securities are being sold without registration under the Securities Act of 1933, relying on exemptions under Section 4(a)(2) (Rule 506 of Regulation D) for the Common Stock and Regulation S for the CDIs. The Company is required to file a registration statement covering the resale of these securities.
Guidance, Outlook, and Risks
Management Commentary: The filing includes a corporate presentation (Exhibit 99.1) furnished under Regulation FD. Management expects the Offering to result in aggregate gross proceeds of approximately US$25 million.
Forward-Looking Statements: The report contains forward-looking statements regarding expected closing dates, gross proceeds, and post-offering cash levels. These are subject to risks and uncertainties.
Risks and Contingencies: Investors are cautioned not to place undue reliance on forward-looking statements. Specific risks are referenced in the Company's Annual Report on Form 10-K for the fiscal period ended December 31, 2024. The Company does not assume an obligation to update these statements.
Investor Verification Checklist
- Verify the final closing dates for both the Common Stock and CDI Offerings against the expected dates of October 27 and October 30, 2025.
- Confirm the actual aggregate gross proceeds received versus the estimated US$25 million.
- Review the filed Registration Statement for the resale of the Shares and Warrants to ensure compliance with SEC requirements.
- Examine the Company's most recent Form 10-K (fiscal year ended December 31, 2024) for detailed risk factors and current liquidity status not included in this 8-K.
- Monitor the dilution impact of the 5,032,960 new shares/CDIs and the associated warrants on existing shareholders.